8-K: Clearwater Paper Reports Mixed Q3 Results Amid Strategic Shift to Paperboard

Clearwater Paper's Q3 results show a significant increase in paperboard sales volume offset by lower prices and the impact of a major maintenance outage, as the company transitions to a focused paperboard business after selling its tissue division.

Summary

• Clearwater Paper reported a net sales increase from total operations to $644 million in Q3 2024, up 24% from $520 million in Q3 2023.
• Net sales from continuing operations were $393 million, a 41% increase year-over-year, primarily due to the Augusta facility.
• The company experienced a net loss from continuing operations of $11 million, or $0.64 per diluted share, compared to a net income of $15 million, or $0.88 per diluted share, in the same quarter last year.
• Net income from total operations was $6 million, or $0.35 per diluted share, down from $37 million, or $2.17 per diluted share, in Q3 2023.
• Adjusted EBITDA from total operations decreased to $64 million from $81 million in the third quarter of the previous year.
• Paperboard sales volumes increased by 67% to 314,320 tons, but average net selling price decreased by 12% to $1,192 per ton.
• For the first nine months of 2024, net sales from total operations were $1.7 billion, a 10% increase year-over-year, but the company reported a net loss of $3 million, or $0.17 per diluted share.
• Adjusted EBITDA from total operations for the first nine months of 2024 was $160 million, compared to $218 million for the same period in 2023.
• The company has approved a new $100 million share repurchase authorization.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company has made strategic moves like selling the tissue business and focusing on paperboard, the financial results show a decline in profitability and pricing pressure. The share repurchase program and long-term outlook provide some positive aspects, but the current performance is concerning.

Positives

• The company saw a significant increase in paperboard sales volume, up 67% year-over-year.
• The sale of the tissue business for $1.06 billion has allowed the company to pay down debt and focus on its core paperboard business.
• A new $100 million share repurchase authorization has been approved, indicating confidence in the company's future.
• The company is targeting a 1-2x net leverage ratio, indicating a strong balance sheet.
• The company is well-positioned to serve independent converters in North America.

Negatives

• The company experienced a net loss from continuing operations of $11 million in Q3 2024.
• Adjusted EBITDA from total operations decreased to $64 million from $81 million in Q3 2023.
• The average net selling price of paperboard decreased by 12% to $1,192 per ton.
• The company reported a net loss from total operations for the first nine months of 2024 of $3 million.
• The company is experiencing challenging SBS industry conditions.

Risks

• The company faces competitive pricing pressures due to capacity additions and demand reduction.
• There are potential risks associated with operating without the tissue business, including less diversification.
• The company may face challenges in integrating the Augusta, Georgia facility.
• The company is exposed to cyclical industry conditions and potential manufacturing disruptions.
• There are risks related to changes in the cost and availability of wood fiber and wood pulp.

Future Outlook

The company expects challenging SBS industry conditions to continue, but remains confident in the long-term fundamentals of paperboard packaging. They are taking actions to reduce costs and are focused on growing and diversifying their paperboard product portfolio. The company anticipates $20 to $30 million of Adjusted EBITDA from total operations in Q4 2024 and an 8% to 10% Adjusted EBITDA margin in 2025.

Management Comments

• We delivered a strong third quarter, even as we dealt with the impact of Hurricane Helene at our Augusta, Georgia and Shelby, North Carolina facilities, said Arsen Kitch, president and CEO.
• We are also pleased that we closed on the sale of our tissue business and are now well positioned to execute on our strategy of building a premier paperboard company that is focused on servicing independent converters in North America.

Industry Context

This announcement reflects a strategic shift in the paper industry, with Clearwater Paper divesting its tissue business to focus on the more stable and growing paperboard market. This move aligns with a trend of companies specializing in core areas to improve efficiency and profitability. The company is positioning itself to capitalize on the paperboard industry's cyclical nature and deliver strong returns.

Comparison to Industry Standards

• Clearwater Paper's paperboard sales volume increase of 67% is significant, indicating successful integration of the Augusta facility, however, the 12% decrease in average selling price reflects broader industry trends of pricing pressure.
• The company's adjusted EBITDA margin of 13-14% is a target across the cycle, which is a reasonable benchmark for the paperboard industry, but the current results are below this target.
• Comparatively, companies like WestRock and Packaging Corporation of America, which are also major players in the paperboard industry, have been facing similar pricing pressures, but their diversified product portfolios may provide some buffer.
• The share repurchase program is a common strategy among companies with strong cash flow, similar to what other industry players have implemented to return value to shareholders.

Management Changes

Stakeholder Impact

• Shareholders will be impacted by the share repurchase program and the company's strategic shift to paperboard.
• Employees will be affected by the organizational changes and the focus on operational efficiencies.
• Customers will benefit from the company's focus on being a premier independent paperboard supplier.
• Suppliers may see changes in demand as the company adjusts its operations.
• Creditors will be impacted by the company's debt reduction and target leverage ratio.

Next Steps

• The company will focus on integrating the Augusta facility and optimizing its paperboard operations.
• Clearwater Paper will continue to evaluate strategic capital investments to diversify its product portfolio.
• The company will opportunistically repurchase shares under the new authorization.
• The company will move to an annual outage schedule to enable smaller, more predictable maintenance outages.

Key Dates

Keywords

paperboard, share repurchase, adjusted EBITDA, tissue business, net sales, operations, packaging, independent converters, Augusta facility, financial results